KLK3 and prostate cancer: With the aim of searching for new serum markers that could assist in the identification of the aggressive prostate cancers, the present study compared the potential of PHI and the percentage of α2,3-sialic of PSA, alone and in combination, to identify high risk PCa cancer in a cohort of 79 patients’ serum samples.